Filing Flows › Cerenome (CNSY) › Q1 2025
Cerenome (CNSY) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 30, 2025
Cerenome (CNSY) reported revenue of $1.1M for the first quarter 2025 (Q1 2025), -37% from a year earlier and -25% from the quarter before. Operating margin was -333.9%.
Cerenome, Q1 2025: revenue $1.1M (-37% year over year), operating margin -333.9%, net loss $17.4M, operating cash flow −$6.2M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | -25% | -37% |
| Operating profit | −$3.5M | — | — |
| Net earnings | −$17.4M | — | — |
| Operating cash flow | −$6.2M | — | — |
What changed
Revenue was $1.1M in Q1 2025, down 37% year over year and down 25% from the previous quarter.
Operating costs exceeded revenue by $3.5M, an operating margin of -333.9%. Total costs fell 8% while revenue fell 37%. The fastest-growing cost line was General & admin (+28%). The quarter ended with a net loss of $17.4M, wider than the previous quarter's $3.9M loss. Net interest and other expense of $13.9M was the main reason.
Operating cash flow was −$6.2M. Non-cash charges added back $146K of depreciation and amortization and $148K of share-based compensation. Working capital and other items added $10.9M. Capital expenditures of $3K exceeded it, leaving free cash flow of −$6.2M.
Questions
What was Cerenome's revenue in the first quarter 2025?
Cerenome (CNSY) reported revenue of $1.1M for the first quarter 2025 (Q1 2025), -37% from a year earlier and -25% from the quarter before.
Was Cerenome profitable in the first quarter 2025?
Operating loss was $3.5M (-333.9% of revenue) and net loss $17.4M.
Source: Cerenome 10-Q on SEC EDGAR.